Skip to content

MDMA (Ecstasy) controls in concert a group of genes involved in GABA neurotransmission.

Rabi Simantov, Weiping Peng

FEBS Letters April 9, 2004 DOI: 10.1016/s0014-5793(04)00256-x (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Peer reviewed
Population MDMA-treated mice
Intervention MDMA
Topics MDMA
Key points MDMA treatment in mice altered expression of GABA transporters and synaptotagmins I and IV, and reduced mRNAs encoding septin and dystrophin. The authors propose that these four protein groups, though from different gene families, converge on GABA neurotransmission and that MDMA may regulate them in a combined fashion, assigning GABA a pivotal role in MDMA's effects.

Abstract

In several countries, 3,4-methylenedioxymethamphetamine (MDMA) is currently the most abundant psychoactive recreational drug. MDMA induces numerous neuropsychiatric behaviors, serotonergic neuron degeneration, programmed death of cultured cells, hyperthermia and occasional fatality. Using gene expression analysis in MDMA-treated mice, we identified changes in gamma-amino butyric acid (GABA) transporters and synaptotagmins I and IV. Additional experiments showed decreases in mRNAs encoding septin and dystrophin. Although belonging to different gene families, it is striking that these four protein groups are implicated in neurotransmission of GABA, a major inhibitory neurotransmitter involved in thermoregulation. MDMA may control these genes in a combined fashion, assigning GABA a pivotal role in MDMA activities.

Citations in the library

Cited by 7

and 2 more in the library

Cites 8

and 3 more in the library

Explore topics